N-Acetylimidazolidinone → HCID 71252675, compound
Reaction equation
[C:1]([N:4]1[CH2:8][CH2:7][NH:6][C:5]1=[O:9])(=[O:3])[CH3:2].Br[C:11]1[CH:12]=[CH:13][C:14]([C:17]([N:19]2[CH2:24][CH2:23][N:22]([C:25]3[C:30]([CH:31]4[CH2:33][CH2:32]4)=[CH:29][C:28]([CH:34]4[CH2:36][CH2:35]4)=[CH:27][N:26]=3)[CH2:21][CH2:20]2)=[O:18])=[N:15][CH:16]=1>>[C:1]([N:4]1[CH2:8][CH2:7][N:6]([C:11]2[CH:16]=[N:15][C:14]([C:17]([N:19]3[CH2:24][CH2:23][N:22]([C:25]4[C:30]([CH:31]5[CH2:33][CH2:32]5)=[CH:29][C:28]([CH:34]5[CH2:35][CH2:36]5)=[CH:27][N:26]=4)[CH2:21][CH2:20]3)=[O:18])=[CH:13][CH:12]=2)[C:5]1=[O:9])(=[O:3])[CH3:2]Participants
3
Procedure
Using 1-acetyl-2-imidazolidinone (462 mg) and (5-bromopyridin-2-yl)[4-(3,5-dicyclopropylpyridin-2-yl)piperazin-1-yl]methanone (1.4 g) described in Preparation Example 142 and by the reaction and treatment in the same manner as in Example 1, the title compound (199 mg) was obtained.
Workup
- customdescribed in Preparation Example 142 and by the reaction and treatment in the same manner as in Example 1
Sources & evidence
- ORD record
- ord-743943f950b1448bbad48506095a3ebe
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08816079B2
Reaction notes
Loading…